palbociclib (Q15269707)

From Wikidata
Jump to navigation Jump to search
drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer
  • PD-0332991
  • PD0332991
  • PD 332991
  • PD 0332991
  • 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one
  • 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one
edit
Language Label Description Also known as
English
palbociclib
drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer
  • PD-0332991
  • PD0332991
  • PD 332991
  • PD 0332991
  • 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one
  • 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one

Statements

0 references
Palbociclib.svg
512 × 267; 7 KB
0 references
447.238 dalton
1 reference
C₂₄H₂₉N₇O₂
1 reference
CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C
1 reference

Identifiers

10219048
1 reference
0 references
810-186-2
1 reference
27 December 2018
6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one (English)
CAS no.: 571190-30-2 (English)
1 reference
27 December 2018
6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one (English)
CAS no.: 571190-30-2 (English)
0 references
1 reference
0 references
0 references
 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit